Year |
Citation |
Score |
2023 |
Henning NJ, Manford AG, Spradlin JN, Brittain SM, Zhang E, McKenna JM, Tallarico JA, Schirle M, Rape M, Nomura DK. Correction to "Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications". Journal of the American Chemical Society. 145: 21142. PMID 37708357 DOI: 10.1021/jacs.3c09174 |
0.813 |
|
2023 |
Moon P, Zammit C, Shao Q, Boike L, Dovala D, Henning NJ, Knapp M, Spradlin JN, Ward CC, Wolleb H, Fuller D, Blake G, Murphy JP, Wang F, Lu Y, et al. Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors. Chembiochem : a European Journal of Chemical Biology. e202300116. PMID 37069799 DOI: 10.1002/cbic.202300116 |
0.706 |
|
2022 |
Page ACS, Scholz SO, Keenan KN, Spradlin JN, Belcher BP, Brittain SM, Tallarico JA, McKenna JM, Schirle M, Nomura DK, Toste FD. Photo-Brook rearrangement of acyl silanes as a strategy for photoaffinity probe design. Chemical Science. 13: 3851-3856. PMID 35432890 DOI: 10.1039/d2sc00426g |
0.766 |
|
2022 |
Henning NJ, Boike L, Spradlin JN, Ward CC, Liu G, Zhang E, Belcher BP, Brittain SM, Hesse MJ, Dovala D, McGregor LM, Valdez Misiolek R, Plasschaert LW, Rowlands DJ, Wang F, et al. Deubiquitinase-targeting chimeras for targeted protein stabilization. Nature Chemical Biology. PMID 35210618 DOI: 10.1038/s41589-022-00971-2 |
0.682 |
|
2022 |
Henning NJ, Manford AG, Spradlin JN, Brittain SM, Zhang E, McKenna JM, Tallarico JA, Schirle M, Rape M, Nomura DK. Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications. Journal of the American Chemical Society. 144: 701-708. PMID 34994556 DOI: 10.1021/jacs.1c03980 |
0.823 |
|
2021 |
Fischer C, Vepřek NA, Peitsinis Z, Rühmann KP, Yang C, Spradlin JN, Dovala D, Nomura DK, Zhang Y, Trauner D. De novo Design of SARS-CoV-2 Main Protease Inhibitors. Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry. 33: 458-463. PMID 35282568 DOI: 10.1055/a-1582-0243 |
0.609 |
|
2021 |
Biering SB, Van Dis E, Wehri E, Yamashiro LH, Nguyenla X, Dugast-Darzacq C, Graham TGW, Stroumza JR, Golovkine GR, Roberts AW, Fines DM, Spradlin JN, Ward CC, Bajaj T, Dovala D, et al. Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2. Acs Infectious Diseases. PMID 34129317 DOI: 10.1021/acsinfecdis.1c00017 |
0.754 |
|
2021 |
Spradlin JN, Zhang E, Nomura DK. Reimagining Druggability Using Chemoproteomic Platforms. Accounts of Chemical Research. PMID 33733731 DOI: 10.1021/acs.accounts.1c00065 |
0.732 |
|
2021 |
Luo M, Spradlin JN, Boike L, Tong B, Brittain SM, McKenna JM, Tallarico JA, Schirle M, Maimone TJ, Nomura DK. Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function. Cell Chemical Biology. PMID 33513350 DOI: 10.1016/j.chembiol.2021.01.005 |
0.77 |
|
2020 |
Tong B, Luo M, Xie Y, Spradlin JN, Tallarico JA, McKenna JM, Schirle M, Maimone TJ, Nomura DK. Bardoxolone conjugation enables targeted protein degradation of BRD4. Scientific Reports. 10: 15543. PMID 32968148 DOI: 10.1038/s41598-020-72491-9 |
0.815 |
|
2020 |
Tong B, Spradlin JN, Novaes LFT, Zhang E, Hu X, Moeller M, Brittain SM, McGregor LM, McKenna JM, Tallarico JA, Schirle M, Maimone TJ, Nomura DK. A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL. Acs Chemical Biology. PMID 32568522 DOI: 10.1021/Acschembio.0C00348 |
0.678 |
|
2020 |
Coles GL, Cristea S, Webber JT, Levin RS, Moss SM, He A, Sangodkar J, Hwang YC, Arand J, Drainas AP, Mooney NA, Demeter J, Spradlin JN, Mauch B, Le V, et al. Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells. Cancer Cell. PMID 32531271 DOI: 10.1016/J.Ccell.2020.05.003 |
0.587 |
|
2019 |
Spradlin JN, Hu X, Ward CC, Brittain SM, Jones MD, Ou L, To M, Proudfoot A, Ornelas E, Woldegiorgis M, Olzmann JA, Bussiere DE, Thomas JR, Tallarico JA, McKenna JM, et al. Harnessing the anti-cancer natural product nimbolide for targeted protein degradation. Nature Chemical Biology. PMID 31209351 DOI: 10.1038/S41589-019-0304-8 |
0.803 |
|
2017 |
Grossman EA, Ward CC, Spradlin JN, Bateman LA, Huffman TR, Miyamoto DK, Kleinman JI, Nomura DK. Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products. Cell Chemical Biology. PMID 28919038 DOI: 10.1016/J.Chembiol.2017.08.013 |
0.746 |
|
Show low-probability matches. |